Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Vibration therapy for muscle stiffness in the legs

Tests a vibrating device for leg muscle stiffness and walking speed in adults.

Plain-language title generated from the registry record
Registry title: Trial to Test the Effectiveness of Vibrotactile Stimulation for Lower Limb Spasticity

Key facts

Where
New York, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT07447934, who can take part

Where in United States

  • Department of Rehabilitation MedicineNew York, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Weill Medical College of Cornell University
Trial code
NCT07447934
Record updated
17 June 2026
Original description
The goal of this clinical trial is to find out if Vibrotactile Stimulation (VTS) can help improve mobility and reduce spasticity (muscle stiffness) in people with lower limb spasticity. The study will also look at how VTS affects walking speed. The main questions it aims to answer are:Read full original descriptionShow less

Vibrotactile Stimulation for Lower Limb Spasticity

The goal of this clinical trial is to find out if Vibrotactile Stimulation (VTS) can help improve mobility and reduce spasticity (muscle stiffness) in people with lower limb spasticity. The study will also look at how VTS affects walking speed. The main questions it aims to answer are:

* Which areas of the body are the best for applying VTS? * Does VTS help improve walking speed in people with lower limb spasticity?

Participants will:

* Receive 15 minutes of VTS treatment on different parts of the body * Use the VTS device for 60 minutes during supervised lab sessions and at home (at rest and while walking) * Complete a daily log of how much time the device was used for and note any issues or difficulties the participant experience * Complete assessments after the treatment to measure change in mobility * Complete surveys about how comfortable the device is to use

Inclusion: ≥6 months following neurologic diagnosis leading to spasticity; Modified Ashworth Scale (MAS) score of 3 or lower on ankle plantar flexor; Ability to stand (with or without assistance) and lie supine; Able to understand and comply with study procedures.

Exclusion: Previous surgery to treat spasticity in the affected lower limb; Prior Botulinum Toxin (BoNT) therapy in the target limb within 4 months; Unstable medication regimens for spasmolysis or muscle relaxation; Participation in tone-related treatments (e.g., physiotherapy, TENS, acupuncture) within 4 weeks prior to baseline. If ongoing treatment started more than 4 weeks before baseline, it should remain consistent throughout the study; Uncontrolled systemic illness or serious medical conditions that could interfere with study procedures.

ClinicalTrials.gov NCT07447934